intoxicant.wiki2catechol4school
Layout
Dissociative

O-PCE

Also called Eticyclidone, Deschloro-N-ethyl-ketamine, 2'-OXO-PCE, N-Ethyldeschloroketamine

Why a "revision used" link? Anyone can edit Wikipedia at any time, so the article you open today may not say what it said when we read it. This link opens the exact version we read on 24 October 2026, frozen as it was. It is the only way to check that every quote on this page matches its source word for word. Newer versions may correct or change things. When we re-check this page against a newer version, the edit log records it. How we cite

Common dose · Oral5–15 mg PW
Onset20–40 minutes PW
Total3–6 hours PW
After-effects4–48 hours PW

Dosage

When sources disagree, both rows are shown as published. Nothing is averaged or merged.

Oral

SourceThresholdLightCommonStrongHeavy
PsychonautWiki1 mg PW3–5 mg PW5–15 mg PW15–25 mg PW25 mg+ PW
TripSit–3–5 mg TS⚠ TripSit's own dose text gives Oral Light as "3-6mg"; the structured value is what the dose text gives for Insufflated.5–10 mg TS⚠ TripSit's own dose text gives Oral Common as "6-11mg"; the structured value is what the dose text gives for Insufflated.10–20 mg. TS–

Insufflated

SourceThresholdLightCommonStrongHeavy
PsychonautWiki2 mg PW3–6 mg PW6–12 mg PW12–20 mg PW20 mg+ PW

TripSit dose text

TripSit's factsheet also states its doses as text.

Oral Light: 3-6mg Common: 6-11mg Strong: 10-20mg. Insufflated Light: 3-5mg Common: 5-10mg Strong: 10-20mg. TS

What dose are you on? (self-reported, unverified)
Read this first. These numbers come from anonymous visitors typing in a box. Nobody checks them. People misjudge, mistype, troll, or take untested products of unknown strength. They are not a dose guide and never override the sourced table above. They exist only so the sourced ranges can be compared with what people say they take. If you are deciding what to take, use the sourced table, start low, and read the risks section.
Running self-reports

No reports yet.

Reports are anonymous, one per browser per day per route. Counts under 20 are shown but marked as too few to mean anything. Until accounts launch, reports stay in this browser only.

Duration

Route · sourceOnsetCome-upPeakOffsetTotalAfter-effects
Oral · PsychonautWiki20–40 minutes PW–––3–6 hours PW4–48 hours PW
Insufflated · PsychonautWiki2–5 minutes PW–––3–5 hours PW2–12 hours PW

TripSit factsheet

Onset
Insufflated: 15-45 minutes · Oral: 25-75 minutes TS
Duration
Insufflated: 2-5 hours · Oral: 3-6 hours TS
Aftereffects
2-48 hours TS

Mixing

Acute combinations: what happens when these are taken close together. Entries backed by a medical journal or agency are listed first.

Backed by medical journals

Awaiting sourcePeer-reviewed reports on acute combinations, from PubMed and the journals the harm reduction sites cite.

Other documented combinations

  • Alcohol - Even low doses of alcohol can cause severe interactions. Nausea, vomiting, amnesia, and other negative effects are extremely likely when mixed. PW⚠ PsychonautWiki lists this combination without a danger rating.

PsychonautWiki also lists dangerous combinations shared across a whole group (dissociatives) in a table this page does not copy. Read that list on PsychonautWiki.

Risks and toxicity

The toxicity and long-term health effects of recreational O-PCE use do not seem to have been studied in any scientific context and the exact toxic dosage is unknown. This is because O-PCE has very little history of human usage. Anecdotal evidence from people who have tried O-PCE within the community suggests that there do not seem to be any negative health effects attributed to simply trying this substance at low to moderate doses by itself and using it sparingly (but nothing can be completely guaranteed). PW

O-PCE shares a close structural relationship to deschloroketamine (O-PCM) and ketamine (2-Cl-O-PCM), which has been speculated to have immuno-modulative properties. It is not known whether O-PCE also has these properties due to the lack of sufficient scientific research. However, the possibility should be kept in mind because prolonged use could potentially pose a serious threat to one's health and immune system.[9] PW

It is strongly recommended that one use harm reduction practices, such as volumetric dosing, when using this substance to ensure the accurate administration of the intended dose. PW

Tolerance and addiction potential

As with other NMDA receptor antagonists, the chronic use of O-PCE can be considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and withdrawal effects may occur if a person suddenly stops their usage. PW

Tolerance to many of the effects of O-PCE develops with prolonged and repeated use. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about 3 - 7 days for the tolerance to be reduced to half and 1 - 2 weeks to be back at baseline (in the absence of further consumption). O-PCE presents cross-tolerance with all dissociatives, meaning that after the consumption of O-PCE all dissociatives will have a reduced effect. PW

Urinary tract effects

In terms of its long-term health effects when used repeatedly and excessively for extended periods of time, O-PCE seems to exhibit similar bladder and urinary tract problems to those found within ketamine, although to what extent is unclear. This is likely because O-PCE is significantly more potent than ketamine, meaning that less of the drug needs to be consumed. Symptoms of ketamine-induced cystitis can become extremely serious and can be described as: PW

  • Urinary frequency - Urinary frequency is the need to empty the bladder every few minutes. PW
  • Urinary urgency - This can be described as a sudden, compelling need to urinate. PW
  • Urinary pressure - This is experienced as a constant sensation of fullness in the bladder that is unrelieved by urination. PW
  • Pelvic and bladder pain - Pain can develop suddenly and severely, particularly as the bladder fills with urine. PW
  • Hematuria - Hematuria is visible blood in the urine. PW
  • Incontinence - This is the leakage of urine. PW

However, anecdotal evidence suggests that these symptoms can be largely avoided by refraining from using O-PCE on a regular basis (e.g. weekly at the bare minimum) and carefully monitoring and limiting one's intake of the substance. PW

TripSit factsheet

Avoid
CNS depressants. TS

Testing

Awaiting sourceReagent reactions and test kit guidance from a harm reduction testing service.

Effects

Awaiting sourceSubjective and physical effects from PsychonautWiki or TripSit.

Overview

2'-Oxo-PCE (also known as as Eticyclidone, and O-PCE) is a lesser-known novel dissociative substance of the arylcyclohexylamine class that produces dissociative, anesthetic, stimulating and hallucinogenic effects when administered. It is structurally related to arylcyclohexylamines like MXE, 3-MeO-PCE, and deschloroketamine and is speculated to produce its effects through its activity as an NMDA receptor antagonist. PW

Dissociative of the Arylcyclohexylamine class. Structurally related to Deschloroketamine. TS

2-Oxo-PCE (also known as N-ethyldeschloroketamine, eticyclidone and O-PCE) is a dissociative anesthetic of the arylcyclohexylamine class that is closely related to deschloroketamine and eticyclidine, and has been sold online as a designer drug.[1–8] WP

History

Awaiting sourceHistory and culture from Wikipedia or PsychonautWiki, with their citations.

Pharmacology

Awaiting sourcePharmacology from Wikipedia and the journal papers it cites.

Chemistry

Formula
C14H19NO PC
CAS number
6740-82-5 PC
Molar mass (g/mol)
217.31 PC
IUPAC name (computed by PubChem)
2-(ethylamino)-2-phenylcyclohexan-1-one PC
SMILES
CCNC1(CCCCC1=O)C2=CC=CC=C2 PC
InChIKey
IDLSBAANXISGEI-UHFFFAOYSA-N PC
PubChem CID
132989542

User reports

Erowid erowid.org

Listings
Awaiting sourceExperience Vault listing and report categories.
Top stories
Awaiting sourceShort summaries of the most-read reports, each linked, saying only what the report says.

Bluelight bluelight.org

Listings
Awaiting sourceTrip report threads and this substance's discussion forum.
Top stories
Awaiting sourceShort summaries of the most-read reports, each linked, saying only what the report says.

Reddit reddit.com

Listings
Awaiting sourceTrip report posts and the relevant subreddits.
Top stories
Awaiting sourceShort summaries of the most-read reports, each linked, saying only what the report says.

Pop culture

No references added yet.

Add a reference

Registered users can add songs, films, books, shows, games and art about this substance. Link a source that names the substance, such as the work's Wikipedia article, a review or an interview, not only the work itself. Entries are voted on and moderated like every other value on this page.

Opens when accounts launch.

References

  1. Other deschloro-N-ethyl-Ketamine (hydrochloride) (CAS 4551-92-2)
  2. Journal / agency Jason W, Brandt SD. New Psychoactive Substances. September 2018. doi:10.1007/164_2018_148 · PMID 30196446
  3. Journal / agency Chong YK, Tang MH, Chan CL, Li YK, Ching CK, Mak TW. 2-oxo-PCE: ketamine analogue on the streets. Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi. December 2017. doi:10.12809/hkmj177089 · PMID 29226843
  4. Journal / agency Tang MH, Chong YK, Chan CY, Ching CK, Lai CK, Li YK, Mak TW. Cluster of acute poisonings associated with an emerging ketamine analogue, 2-oxo-PCE. Forensic Science International. September 2018. doi:10.1016/j.forsciint.2018.07.014 · PMID 30081327
  5. Journal / agency Tang MH, Hung LY, Lai CK, Ching CK, Mak TW. 9-year review of new psychoactive substance use in Hong Kong: A clinical laboratory perspective. Hong Kong Journal of Emergency Medicine. September 2018. doi:10.1177/1024907918798553
  6. Journal / agency Li C, Lai CK, Tang MH, Chan CC, Chong YK, Mak TW. Ketamine analogues multiplying in Hong Kong. Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi. April 2019. doi:10.12809/hkmj197863 · PMID 30971512
  7. Journal / agency Theofel N, Möller P, Vejmelka E, Kastner K, Roscher S, Scholtis S, Tsokos M. A Fatal Case Involving N-Ethyldeschloroketamine (2-Oxo-PCE) and Venlafaxine. Journal of Analytical Toxicology. March 2019. doi:10.1093/jat/bky063 · PMID 30365028
  8. Journal / agency Tamama K, Lynch MJ. Substance Use Disorders. October 2019. doi:10.1007/164_2019_260 · PMID 31595417
  9. Other Stevens, C. L. Aminoketones and methods for their production

Text and values on this page are quoted from PsychonautWiki (CC BY-SA 4.0), Wikipedia (CC BY-SA 4.0), TripSit factsheets, PubChem (public domain). Each value links to the exact revision it came from.